News 13.04.2022 ZÜRICH, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics based on its proprietary antibody-based MHC-targeting T cell engager technology, today announced the closing of a $76 million Series A financing led by Jeito Capital and...
Events, Internal events
Event date: 03.05.2022
Do you have questions about possibilities to protect your invention, specific questions about current patent prosecution, or do you need advice regarding your IP portfolio? Join us for free counselling on May 03, 2022 in the rooms of Bio-Technopark Schlieren-Zürich at Wagistrasse 23 before the Networking Aperitif.
We are European patent...
Events, External events
Event date: 10.05.2022
10:00am–12:45pm CEST
A free, virtual event featuring European biotech founders, investors, scientists and industry experts who will share their strategies for lasting success.
There’s never been a better time to be part of a biotech startup. Yet, building a successful biotech company is no easy feat. Decisions you make early on can have...
Events, External events
Event date: 09.06.2022
An international conference on Drug Discovery will be organized at ZHAW in Wädenswil, Switzerland. This biological and chemical meeting will focus on pharmaceutical drug discovery. We expect about 150 participants from the fields of chemistry, pharma, biology and medicine. The program of the meeting is available:
(https://www.zhaw.ch/de/lsfm/weiterbildung/fachtagungen/day-of-life-sciences/ )
In this context, the...
Events, External events
Event date: 19.05.2022
Program is out!
We’re excited to let you know that our friends from @startup days have announced their insightful conference program: https://www.startupdays.ch/program-22/
Discover more than 100 brilliant speakers and the 50 insightful sessions categorized into four tracks: inspiration, learning, scaling, and pitching. The diverse program covers topics from female empowerment to cybersecurity...